These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19131605)

  • 1. Biomedicine. A new view on--and hope for--an old disease.
    Cahoon L
    Science; 2009 Jan; 323(5911):203-5. PubMed ID: 19131605
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.
    Jozwiak J; Jozwiak S; Oldak M
    Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of tuberous sclerosis complex.
    Crino PB
    Epilepsia; 2010 Feb; 51 Suppl 1():27-9. PubMed ID: 20331708
    [No Abstract]   [Full Text] [Related]  

  • 4. "TOR"rific potential for new human therapies?
    McKhann GM
    Neurosurgery; 2009 May; 64(5):N14-5. PubMed ID: 19404136
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in neurobiology of Tuberous Sclerosis Complex.
    Napolioni V; Moavero R; Curatolo P
    Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal brain malformations: seizures, signaling, sequencing.
    Crino PB
    Epilepsia; 2009 Oct; 50 Suppl 9():3-8. PubMed ID: 19761448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy.
    Crino PB
    Ann Neurol; 2008 Apr; 63(4):415-7. PubMed ID: 18360828
    [No Abstract]   [Full Text] [Related]  

  • 8. mTOR in tuberous sclerosis and other neurological disorders.
    Franz DN
    Epilepsia; 2007 Aug; 48(8):1630-1; author reply 1632-4. PubMed ID: 17692052
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric epileptology.
    Sahin M; Miller I; Holmes GL; Sheth RD
    Epilepsy Behav; 2011 Sep; 22(1):32-7. PubMed ID: 21530413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.
    Paul E; Thiele E
    N Engl J Med; 2008 Jan; 358(2):190-2. PubMed ID: 18184966
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of epilepsy in tuberous sclerosis complex.
    Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
    Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advance in tuberous sclerosis-related genes and their expression].
    Liu J; Piao YS; Lu DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):210-2. PubMed ID: 20450774
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberous sclerosis: genes, brain, and behaviour.
    Curatolo P
    Dev Med Child Neurol; 2006 Jun; 48(6):404. PubMed ID: 16700926
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomedicine. A discriminating killer.
    Cahoon L
    Science; 2009 Jan; 323(5911):204. PubMed ID: 19131606
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare diseases offer insights into autism spectrum disorders. Preliminary laboratory studies suggest new biological targets for intervention.
    Harv Ment Health Lett; 2009 Apr; 25(10):3. PubMed ID: 19475765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuro-encephalic features of tuberous sclerosis complex].
    Belfquih H; El Mostarchid B; Akhaddar A; Gazzaz M; Boucetta M
    Rev Med Interne; 2012 Aug; 33(8):433-8. PubMed ID: 22658530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual clinical presentation of tuberless tuberous sclerosis complex.
    Kaufmann R; Kornreich L; Goldberg-Stern H
    J Child Neurol; 2009 Mar; 24(3):361-4. PubMed ID: 19258298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of mTOR in tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):259-64. PubMed ID: 19143643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlations in tuberous sclerosis: who and how to treat.
    Goh S; Weiss WA
    Ann Neurol; 2006 Nov; 60(5):505-507. PubMed ID: 17120247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.